19 January 2026 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on five medicines.

Exagamglogene autotemcel (Casgevy) was accepted for the treatment of sickle cell disease in patients who are 12 years and older. It is for people who can have a stem cell transplant but do not have a suitable donor.

Read SMC press release